INMB

INmune Bio Inc. - Common stock (INMB)

About INmune Bio Inc. - Common stock (INMB)

INmune Bio, Inc. is a clinical stage biotechnology company, which engages in developing new immunotherapies that reprogram the immune system to fight cancer and Alzheimer’s disease. The company was founded by Mark Lowdell on September 25, 2015 and is headquartered in Boca Raton, FL.

Details

Daily high

$2.40

Daily low

$2.21

Price at open

52 Week High

$2.60

52 Week Low

$1.09

Market cap

64.7M

Dividend yield

Volume

358

Avg. volume

366,436

P/E ratio

-3.36

INmune Bio Inc. - Common stock News